Market Tracker

09/27 4:47pm ET

Repros Therapeutics Inc (NASDAQ:RPRX)

2.09
Delayed Data
As of Sep 27
 +0.02 / +0.97%
Today’s Change
0.80
Today|||52-Week Range
8.35
+72.73%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close2.07
Today’s open2.09
Day’s range2.06 - 2.12
Volume64,658
Average volume (3 months)433,147
Market cap$50.3M
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+13.67%
Earnings growth (this year)+42.92%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
IMMYImprimis Pharmaceuti...+0.01+0.27%
NVETNexvet Biopharma plc-0.15-3.59%
PTXPernix Therapeutics ...-0.02-4.08%
MTEXMannatech Inc+0.51+2.84%
Data as of 3:59pm ET, 09/27/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$29.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts